PTC Therapeutics, Inc. (PTCT)
70.09
-1.72
(-2.40%)
USD |
NASDAQ |
Aug 28, 16:00
70.04
-0.05
(-0.07%)
After-Hours: 20:00
PTC Therapeutics Free Cash Flow : -332.49M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -332.49M |
| March 31, 2026 | -516.71M |
| December 31, 2025 | 411.25M |
| September 30, 2025 | 446.32M |
| June 30, 2025 | 681.04M |
| March 31, 2025 | 679.22M |
| December 31, 2024 | -181.94M |
| September 30, 2024 | -274.19M |
| June 30, 2024 | -230.01M |
| March 31, 2024 | -199.47M |
| December 31, 2023 | -279.04M |
| September 30, 2023 | -343.25M |
| June 30, 2023 | -363.72M |
| March 31, 2023 | -403.42M |
| December 31, 2022 | -509.11M |
| September 30, 2022 | -409.03M |
| June 30, 2022 | -421.96M |
| March 31, 2022 | -395.50M |
| December 31, 2021 | -336.66M |
| September 30, 2021 | -327.02M |
| June 30, 2021 | -249.86M |
| March 31, 2021 | -271.06M |
| December 31, 2020 | -250.05M |
| September 30, 2020 | -193.10M |
| June 30, 2020 | -221.28M |
| Date | Value |
|---|---|
| March 31, 2020 | -204.87M |
| December 31, 2019 | -144.08M |
| September 30, 2019 | -142.07M |
| June 30, 2019 | -115.87M |
| March 31, 2019 | -65.03M |
| December 31, 2018 | -43.17M |
| September 30, 2018 | 0.355M |
| June 30, 2018 | -14.80M |
| March 31, 2018 | -77.56M |
| December 31, 2017 | -90.33M |
| September 30, 2017 | -124.13M |
| June 30, 2017 | -131.48M |
| March 31, 2017 | -92.62M |
| December 31, 2016 | -105.34M |
| September 30, 2016 | -122.08M |
| June 30, 2016 | -126.08M |
| March 31, 2016 | -131.60M |
| December 31, 2015 | -127.06M |
| September 30, 2015 | -107.27M |
| June 30, 2015 | -96.28M |
| March 31, 2015 | -85.62M |
| December 31, 2014 | -61.94M |
| September 30, 2014 | -65.27M |
| June 30, 2014 | -53.47M |
| March 31, 2014 | -53.52M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.49B |
| BioMarin Pharmaceutical, Inc. | 725.08M |
| Arcturus Therapeutics Holdings, Inc. | -78.18M |
| Spruce Biosciences, Inc. | -42.77M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 129.11M |
| Cash from Investing (Quarterly) | -122.56M |
| Cash from Financing (Quarterly) | 211.88M |
| Free Cash Flow Per Share (Quarterly) | 1.326 |
| Free Cash Flow to Equity (Quarterly) | -179.41M |
| Free Cash Flow to Firm (Quarterly) | 163.47M |
| Free Cash Flow Yield | -5.54% |